baicalin has been researched along with Cachexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Gan, R; Guo, C; Han, Y; Li, B; Li, Y; Wan, L; Yang, Q; Yu, Q | 1 |
| Bertona, M; Emanuele, E; Fiuza-Luces, C; Lucia, A; Morales, JS; Pareja-Galeano, H; Sanchis-Gomar, F | 1 |
2 other study(ies) available for baicalin and Cachexia
| Article | Year |
|---|---|
Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Topics: Animals; Anorexia; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cachexia; Cell Line, Tumor; Cytokines; Disease Models, Animal; Enzyme Activation; Flavonoids; Heterografts; Humans; Male; Mice; Muscular Atrophy; Neoplasms; NF-kappa B; Organ Size; Plant Extracts; Scutellaria baicalensis | 2014 |
Baicalin supplementation reduces serum biomarkers of skeletal muscle wasting and may protect against lean body mass reduction in cancer patients: Results from a pilot open-label study.
Topics: Absorptiometry, Photon; Activins; Aged; Biomarkers; Body Weight; Cachexia; Endpoint Determination; Female; Flavonoids; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Neoplasms; NF-kappa B; Pilot Projects; Wasting Syndrome; Weight Loss | 2016 |